证券代码：600623 900909 股票简称：华谊集团 华谊 B 股 编号：2025-041 上海华谊集团股份有限公司 关于现金收购股权暨关联交易的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、关联交易概述 上海华谊集团股份有限公司（以下简称"华谊集团"或"公司"）于 2025 年 5 月 6 日召开第十一届董事会第四次会议，审议通过了《关于收购上海华谊三爱 富新材料有限公司 60%股权暨关联交易的议案》，公司同意以现金方式收购上海 华谊控股集团有限公司（以下简称"上海华谊"）持有的上海华谊三爱富新材料 有限公司（以下简称"三爱富"）60%股权，并与上海华谊就本次交易签署附条 件生效的《股权收购协议》。具体内容详见公司于 2025 年 5 月 7 日在上海证券交 易所网站（www.sse.com.cn）上披露的《上海华谊集团股份有限公司关于现金收 购股权暨关联交易的公告》（公告编号：2025-032）。 公司于 2025 年 5 月 30 日召开 2024 年年度股东大会，审议通过了《关于收 购上海华谊三爱富 ...

证券代码：600623 900909 股票简称：华谊集团 华谊 B 股 编号：2025-039 该议案同意票数为 7 票，反对票数为 0 票，弃权票数为 0 票。 上海华谊集团股份有限公司 第十一届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海华谊集团股份有限公司（以下简称"公司"）第十一届董事会第六次会 议，于 2025 年 6 月 30 日以通讯表决方式召开，应到董事 7 人，实到董事 7 人， 公司监事及部分高级管理人员列席会议，会议由董事长顾立立先生主持，符合《公 司法》、公司《章程》的规定，会议合法有效。 经审议、逐项表决，会议通过如下议案： 一、审议通过了《关于修订<公司章程>及配套议事规则并取消监事会的议 案》。 具体事宜详见关于修订公司章程的公告（临时公告编号：2025-040）。 该议案同意票数为 7 票，反对票数为 0 票，弃权票数为 0 票。 该议案尚需提交股东大会审议通过。 二、审议通过了《关于修订董事会各专门委员会实施细则的议案》。 (内容详见上海证券交易所网站 htt ...

Investment Rating - The industry investment rating is "Positive (Maintain)" [5] Core Viewpoints - The ongoing conflict between Israel and Iran has significantly increased the risk premium for oil and gas, impacting prices and market dynamics [8][17] - There is a heightened focus on Iranian chemical products due to their substantial global production and export share, particularly methanol and ethylene glycol [8][17] - The report highlights that even if Iranian oil exports cease, other suppliers like OPEC+ can quickly fill the gap, but damage to Iranian chemical production facilities could have long-term effects [8][17] Price Changes - The report monitors 188 chemical products, with the top three price increases being crude oil (up 13.7%), paraxylene (up 10.5%), and WTI (up 10.4%); the largest declines were in liquid chlorine (down 60.0%), vitamin E (down 14.2%), and acrylic short fiber (down 7.9%) [14][18] - The report also notes significant changes in price spreads, with the largest increases in BDO spread (up 6955.9%), hydrogen peroxide spread (up 500.0%), and butyl acrylate spread (up 97.7%); the largest declines were in R410a spread (down 25100.0%), PTA (down 38.5%), and PTMEG spread (down 22.8%) [18][19] Investment Recommendations - The report recommends buying shares in companies that are expected to benefit from the price increases due to the Israel-Iran conflict, including Huayi Group (600623), Baofeng Energy (600989), Satellite Chemical (002648), and Wankai New Materials (301216) [8] - It also suggests focusing on agricultural chemical companies with differentiated growth logic, such as Yangnong Chemical (600486) and Runfeng Shares (301035), as well as companies less affected by overseas fluctuations, including Guoguang Shares (002749), Hualu Hengsheng (600426), and Huamao Technology (603181) [8]

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [2][8]. Core Insights - The company, Huayi Group, operates under five core diversified business segments and plans to acquire a 60% stake in San Aifu, enhancing its growth potential in the fine fluorochemical sector [5][6][8]. - In 2024, Huayi Group achieved a revenue of 44.6 billion yuan, reflecting a year-on-year growth of 9.3%, and a net profit of 910 million yuan, up by 5.8% [5]. - The acquisition of San Aifu, a top 20 global fluorochemical company, is expected to strengthen Huayi's position in the fine fluorochemical market and expand its new materials product matrix [6][8]. Financial Performance - The company reported a total market capitalization of approximately 16.09 billion yuan and a circulating market capitalization of about 14.13 billion yuan as of June 18, 2025 [4]. - The projected revenues for 2025, 2026, and 2027 are estimated at 45.83 billion yuan, 47.16 billion yuan, and 48.41 billion yuan, respectively, with corresponding net profits of 938 million yuan, 1.14 billion yuan, and 1.23 billion yuan [8][10]. - The company has a cash dividend plan for 2024, proposing a distribution of 0.18 yuan per share, resulting in a cash dividend ratio of 41.96% [7]. Business Strategy - Huayi Group focuses on a dual-core business model of "manufacturing + services" and aims to integrate its upstream and downstream supply chains [5]. - The company is committed to enhancing its core business in chemicals while aligning with national strategies and regional development initiatives [7].

证券代码：600623 900909 股票简称：华谊集团 华谊 B 股 编号：2025-038 上海华谊集团股份有限公司 综上，公司应回购上述合计 8,618,318 股限制性股票。（以下简称"本次回 购注销"） 回购股份数量（股） 注销股份数量（股） 注销日期 一、本次回购注销的决策与信息披露 （一）2024 年 12 月 30 日，公司召开了第十届董事会第三十六次会议、第 十届监事会第三十六次会议，审议通过了《关于回购注销部分激励对象已获授但 尚未解除限售的限制性股票并调整回购价格的议案》，同意公司按照相关规定回 购并注销合计 5,265,172 股限制性股票。具体内容详见上海证券交易所网站 （http://www.sse.com.cn）《上海华谊集团股份有限公司关于回购注销部分限制 性股票并调整回购价格的公告》（临时公告编号：2024-054）。 上述《关于回购注销部分激励对象已获授但尚未解除限售的限制性股票并调整回 购价格的议案》。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： （1）根据上海华谊集团 ...

证券代码：600623 900909 股票简称：华谊集团 华谊 B 股 编号：2025-038 上海华谊集团股份有限公司 关于部分限制性股票回购注销实施的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1、本次回购注销原因： （1）根据上海华谊集团股份有限公司（以下简称"公司"或"华谊集团"） 2025 年第一次临时股东大会决议，鉴于 A 股限制性股票激励计划（以下简称"本 次激励计划"）激励对象离职、达到法定退休年龄正常退休或因组织安排调离公 司、董事会认定等原因不再满足成为激励对象条件并结合公司层面业绩考核情 况，公司应回购并注销合计 5,265,172 股限制性股票。 （2）根据公司 2025 年第二次临时股东大会决议，鉴于本次激励计划公司部 分激励对象个人绩效评价结果为良好，部分激励对象因离职、达到法定退休年龄 正常退休或因组织安排调离公司等原因不再满足成为激励对象条件，并结合2022 年度及 2023 年度公司层面业绩考核情况以及激励对象所属子公司的实际业绩完 成情况，公司应回购并注销合计 3, ...

国浩律师(上海)事务所 关 于 上海华谊集团股份有限公司 为出具本法律意见书,本所律师特作如下声明: 一、本所及经办律师依据《公司法》《证券法》《管理办法》等规定及本法 律意见书出具目以前已经发生或者存在的事实,严格履行了法定职责,遵循了勤 勉尽责和诚实信用原则,对公司本次激励计划的合法合规性进行了充分的核查验 证,保证本法律意见书不存在虚假记载、误导性陈述及重大遗漏。 二、本所律师同意将本法律意见书作为公司本次激励计划所必备的法律文件, 随同其他材料一同上报,并依法对出具的法律意见承担法律责任。本所律师同意 公司在其为实行本次激励计划所制作的相关文件中引用本法律意见书的相关内 容,但公司做上述引用时,不得因引用而导致法律上的歧义或曲解,本所律师有 权对上述相关文件的相应内容再次审阅并确认。 ▲ 股限制性股票激励计划部分限制性股票回购注销实施的 法律意见书 国浩律师(上海)事务所 RANDALL LAW FIRM(SHANGHAI) 二〇二五年六月 国浩律师(上海)事务所 法律意见书 致:上海华谊集团股份有限公司 国浩律师(上海)事务所(以下简称"本所")接受上海华谊集团股份有限 公司(以下简称"华谊集团"或 ...

Core Viewpoint - The acetic acid ethyl ester (EA) industry in China is experiencing a significant recovery in production capacity and output in 2024, driven by new installations and increasing export demand, despite previous challenges related to overcapacity and environmental regulations [1][4][10]. Industry Overview - Acetic acid ethyl ester is a widely used fine chemical product and an important organic solvent, primarily consumed in the coatings, pharmaceuticals, and adhesives sectors, which together account for over 80% of its downstream consumption [2][4]. - The industry has seen a production capacity increase to 4.3 million tons in 2024, representing a year-on-year growth of 21.1% [4][20]. Production Side - The production of acetic acid ethyl ester in China began in the 1970s, with significant growth in capacity observed in the 21st century, reaching 3.53 million tons by 2013 [4]. - In 2024, the total production volume is expected to reach 2.4 million tons, marking a 16.05% increase from the previous year, with the industry capacity utilization rate remaining above 50% for three consecutive years [4][10]. Import and Export - China has achieved self-sufficiency in acetic acid ethyl ester, with imports remaining below 0.15 million tons. However, exports are on the rise, projected to exceed 500,000 tons in 2024, reflecting a 19.3% increase [8][21]. - The average export price has been declining, with a 10.03% drop expected in 2024, indicating intensified competition in international markets [8][12]. Consumption Side - The demand for acetic acid ethyl ester has been weak in traditional sectors like coatings and adhesives due to adjustments in the real estate market, leading to a supply-demand imbalance [10][12]. - The apparent consumption volume is projected to reach 188,450 tons in 2024, showing a year-on-year growth of 15.19% as exports expand [10][12]. Competitive Landscape - The acetic acid ethyl ester market in China is characterized by intense competition among both international chemical giants and domestic companies such as Hualu Hengsheng, Jiangsu Sopo, and others [14][16]. - The market concentration is decreasing, with the CR3 dropping from 43.7% in 2023 to 38.4% in 2024, indicating a more fragmented competitive environment [20]. Development Trends 1. **Capacity Expansion and Increased Competition**: The industry is set to add 480,000 tons of new capacity in 2025, intensifying market competition and pressuring smaller firms [20]. 2. **Export Market as Growth Engine**: The export volume is expected to continue rising, particularly in Southeast Asia, driven by domestic capacity release and cost advantages [21]. 3. **Optimizing Downstream Demand Structure**: The demand for acetic acid ethyl ester is shifting towards high-end applications in coatings and pharmaceuticals, while traditional sectors face slower growth [22]. 4. **Accelerated Green and Smart Transformation**: The industry is moving towards greener and smarter production methods, including the use of new catalysts and biotechnological processes [23].

Group 1: Wens Foodstuff Group (温氏股份) - Wens Foodstuff Group has made significant progress in chicken and pig farming technology and cost control, with the comprehensive cost of pork farming reduced to 6-6.1 yuan per jin and the total cost of chicken farming reduced to 5.5-5.6 yuan per jin [1] - The company continues to focus on pig fattening and sales, having sold 1.01 million piglets from January to May 2025, and does not plan to entrust breeding pigs to cooperative farmers [1] - The company believes its competitive advantage in the pig farming industry lies in cost reduction and efficiency improvement, with effective disease prevention and stable production [1] Group 2: Huayi Group (华谊集团) - Huayi Group's subsidiary, San Aifu, specializes in the R&D, production, and sales of fluorinated chemicals, with a projected net profit of 275 million yuan in 2024, driven by an increase in product volume [1] - The company is expanding its production lines and continuously investing to maintain technological and channel leadership, especially as refrigerant patents expire [1] - Huayi Group has announced a cash dividend of 0.18 yuan per share (including tax), with a cash dividend ratio increased to 41.96%, emphasizing its commitment to sharing business development results with investors [1]

Group 1: Xunluo Electronics (顺络电子) - The company has a full order book and high capacity utilization in Q2 [1] - The automotive electronics business covers electrification and intelligent scenarios, with a broad product line and good development prospects [1] - The data center business shows significant sales growth, providing various products and solutions [1] - Increased demand for power inductors from AI smartphones enhances the value of individual components [1] - The company has a rich variety of integrated inductors with wide applications and a promising market outlook [1] - The industry has high barriers to entry, positioning the company as a leading player with multiple core advantages [1] - The company is continuously expanding production and investing in R&D, with no immediate financing plans [1] Group 2: San Aifu (三爱富) - The company primarily engages in the R&D, production, and sales of fluorinated chemicals, with a projected net profit of 275 million yuan in 2024 [2] - Growth is driven by an increase in product volume, with some production lines at the Shaowu base gradually starting operations [2] - Future growth will come from existing products, industrial transfer, and domestic substitution [2] - The company's products are widely used in downstream industries such as new energy, electronics, and aerospace, with some products holding leading market shares [2] - The expiration of refrigerant patents will lead to new production lines and processes being developed [2] - The PVDF market is expected to have sufficient supply in the coming years, with the company having advantages in the supply chain and cost [2] - The company has a diverse range of customized polymer products, with stable overall performance [2] - The company is actively seeking new applications and markets for existing products while developing new ones [2] - A valuation enhancement plan for 2025 has been established, with a focus on cash dividends to enhance investor returns [2] - The company plans to distribute a cash dividend of 0.18 yuan per share, increasing the cash dividend ratio to 41.96% [2] - The company is monitoring regulatory trends regarding B-shares and responding to market feedback [2]